Viewing StudyNCT00466466



Ignite Creation Date: 2024-05-05 @ 5:28 PM
Last Modification Date: 2024-10-26 @ 9:32 AM
Study NCT ID: NCT00466466
Status: COMPLETED
Last Update Posted: 2020-12-21
First Post: 2007-04-26

Brief Title: Safety of RAD001 in Combination With Cisplatin and Etoposide in Lung Cancer Patients
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Small-Cell Lung Cancer
Keywords:
Name View
Etoposide View
Small-Cell Lung Cancer View
SCLC View
Advanced Lung Cancer View
RAD View
RAD001 View
Chemotherapy View
Cisplatin View